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This study investigated the antinociceptive mechanisms of khat extract (100, 200, and 
400 mg/kg, i.p.) in four pain models: two thermic (hot plate, tail-flick) and two chemical 
(acetic acid, formalin) models. Male mice were pretreated intraperitoneally (i.p.) with the 
opioid receptor blocker naloxone (5 mg/kg), the cholinergic antagonist atropine (2 mg/
kg), the selective α1 blocker prazosin (1 mg/kg), the dopamine D2 antagonist haloperidol 
(1.5 mg/kg), or the GABAA receptor antagonist, bicuculline (1 mg/kg) 15 minutes prior to 
i.p. injection of khat extract (400 mg/kg). Khat extract reduced the nociceptive response 
of mice in the four pain tests. Naloxone significantly inhibited the antinociceptive effect 
of khat extract in the hot plate, tail-flick, and the first phase of formalin tests. Bicuculline 
significantly antagonized the antinociceptive effect of khat extract on the hot plate and 
tail-flick tests. Haloperidol significantly reversed the antinociceptive effect of khat extract 
on the tail-flick test and the first phase of formalin test. These results provide strong 
evidence that the antinociceptive activity of khat extract is mediated via opioidergic, 
GABAergic, and dopaminergic pathways. The mechanism of the antinociceptive action 
of khat may be linked to the different types of pain generated in animal models.
Keywords: khat (Catha edulis), hot plate, formalin, tail flick, opioidergic, dopaminergic, gaBaergic
inTrODUcTiOn
Pain is a common reason to seek medical consultation due to its high prevalence (1). Both short-
term and chronic use of most of the current pain medications such as NSAIDs and opioids is 
associated with many adverse effects and potential interactions with other medications (2). This 
explains the increasing interest in the use of herbal medicine as an alternative or adjuvant for 
classic analgesics (3). Khat (Catha edulis) is a medium-sized evergreen tree of psychostimulant 
nature that is cultivated in Yemen and East African countries (4). Chewing of khat leaves is a 
traditional habit in different populations to alleviate fatigue and produce analgesia (5–7). Detailed 
description of chemical and pharmacological profile and negative health impact of khat abuse 
were documented and critically reviewed (8, 9).
Among 20 psychoactive substances, khat is considered as the least harmful herb of low 
dependence potential (10). The major active constituents of khat extract include six major 
alkaloids, tannins, and flavonoids (11). The WHO recommended that the potential for abuse 
and dependence of khat and its constituents is low and that its impact on public health do 
not warrant international control (12). Moreover, khat has some positive characteristics, which 
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encourage its further studies. These effects include lowering of 
plasma cholesterol and reduction in glucose and triglycerides 
concentration (13) in addition to its potent cytotoxicity and 
antibacterial activity (14). These effects are predominantly 
due to cathinone, the main psychoactive component in khat. 
Interestingly, the use of khat could be beneficial in pain 
management due to the poor abuse liability of the active 
constituents. Earlier studies have demonstrated prolonged 
analgesic effect induced by cathinone (15) and khat in ani-
mal models (16, 17). Both opiate (16) and non-opiate (15, 
18) pathways have been suggested as a mechanism for the 
antinociceptive action of khat. However, the identification of 
the exact receptors mediating the antinociceptive action of 
khat is not investigated.
The process of pain is a complex phenomenon that is con-
nected to the type of the painful stimulus, the type of nerves 
involved in pain transmission, and the neurotransmitters 
released (19). The link between the antinociceptive effect of khat 
and the type of pain elicited by the nociceptive signal has not 
been addressed. Different nociceptive stimuli including ther-
mal, chemical, and inflammatory signals activate specific types 
of nerve fibers, namely, Aδ and C fibers (20, 21). The difference 
in the mechanism of action of analgesic agents as opioids based 
on the pain test has been documented (22). Although numerous 
studies have investigated the antinociceptive effect of cathinone, 
only few studies have dealt with the effects of whole material, 
as normally taken by users and none of these studies addressed 
the link between the antinociceptive effect of khat and the 
type of painful stimulus and if there is a direct evidence of the 
involvement of different neurotransmitters in the antinocicep-
tive action of khat following acute administration. In this study, 
we investigated the antinociceptive mechanisms of khat extract 
in relation to the type of pain tested. Two chemical pain tests, 
acetic acid-induced writhing and formalin-induced licking in 
addition to two thermal models, hot plate and tail-flick tests 
were performed on mice. The involvement of different recep-
tors in the antinociceptive action of khat was also investigated 
using the opioid antagonist naloxone, the cholinergic antagonist 
atropine, the selective α1 blocker prazosin, the dopamine D2 
antagonist haloperidol, and the GABAA receptor antagonist, 
bicuculline.
MaTerials anD MeThODs
animals
Male Swiss mice (30–40  g) from King Fahd Medical Research 
Center, King Abdulaziz University, Jeddah, Saudi Arabia were 
used in the present study. The mice were kept in cages under 
standardized conditions with 12/12  h light/dark cycle in a 
temperature-controlled room at 22 ± 2°C with free access to food 
and water. The study was performed according to the institutional 
recommendations for the care and use of experimental animals 
of the research and ethics committee, ethical approval No. 
109/1438/BR. The protocol was approved by the research ethical 
committee, substance of abuse research center. All animals were 
used only for one procedure and were humanely sacrificed under 
anesthesia after the completion of experiment. The experiments 
were performed by an observer blind to the treatment type.
Drugs
Morphine sulfate, diclofenac sodium, and haloperidol were 
from Jamjoom Pharma Factory (Jeddah, KSA). Bicuculline and 
atropine sulfate were from Sigma Chemical Co. (St. Louis, MO, 
USA). Prazosin and naloxone were from Tabuk Pharmaceuticals 
Manufacturing Company (Kingdom of Saudi Arabia). Atropine 
sulfate, morphine, and naloxone were dissolved in saline. 
Bicuculline was dissolved in normal saline with few drops of 
concentrated acetic acid 97% (23). Haloperidol ampoule (5 mg/
mL) was diluted in saline.
Preparation of Khat extract
A total of 300 g of fresh plants of C. edulis (stem tips and leaves) 
were provided by Substance Abuse Research Center (Jizan 
University). The transported fresh packed bundles were carried 
on the same day in an ice box to the laboratory and stored at 
−20°C overnight. The dried plants were washed with distilled 
water to remove dust and debris and dried in freeze dryer for 
two nights. The dried leaves (weighed 88 g) were crushed with 
pestle in a mortar and immersed with ethanol 96% in a flask (24). 
The mixture of khat material and ethanol was stirred gently and 
then left to stand overnight wrapped with aluminum foil to avoid 
light-induced decomposition. The content was later filtered, first 
by use of gauze roll to separate the big particles followed by filter 
paper to remove the fine particles (25). The filtrate was evaporated 
under rotary pump to remove ethanol then, in a vacuum at 40°C 
to remove all traces of ethanol. The resulting ethanol-free extract 
(12 g) constituted 4% of the original fresh material (26). Extracts 
were stored in refrigerator after wrapping in parafilm. The batch 
of 300  g of fresh leaves bundles produced 12  g of dry extract 
representing 100:4 leaf-to-extract extraction ratio. Khat extract 
was freshly dissolved in normal saline and kept in refrigerator 
at 4°C prior to use. The identity of the active constituents was 
confirmed by mass spectroscopy and showed that both cathinone 
and cathine existed in approximately equal concentration.
Mass spectra
A weight of 20 mg of sample powder was extracted by 5 mL of 
methanol, filtered through 0.45 µm nylon filter, dried with nitro-
gen gas, and the residue was reconstituted in 50 μL methanol. A 
volume of 5 μL was injected for LC-MS analysis (Agilant 6300 
Ion trap, USA) applying positive-Auto-MSn mode. A representa-
tive MS chromatogram (extracted ion chromatogram) showed 
cathinone m/z 134 at 6.6  min and cathine m/z 132 at 7.5  min 
(Figure 1). The average MS spectra were confirmed by NIST2008 
database.
experimental groups and Protocols
Animal Testing
Acetic Acid-Induced Abdominal Writhing
The experimental groups of mice (n  =  6) were treated with 
khat extract (i.p.) 30  min before the administration of 0.6% 
acetic acid solution (10 mL/kg, i.p.). Injection of acetic acid in 
FigUre 1 | Ms/Ms chromatogram (Ms2) of m/z 150 ( 132) and 152 ( 134). Cathine, at 6.6 min; cathinone at 7.5 min.
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mice showed characteristic abdominal constrictions in the form 
of muscle contraction joined with hind limb stretching  (27). 
The nociception intensity was quantified by counting the total 
number of writhings within 30 min after acetic acid injection.
Formalin-Induced Pain
The animals were treated with 50 μL of 1% formalin in region 
of the right hind paw. Following formalin injection, the mouse 
injected paw was observed for 30  min in an acrylic box. The 
time for licking the paw was observed in two phases, 0–5 min 
(neurogenic pain), and 15–30 min (inflammatory pain) (28).
Hot Plate Test
Each mouse was placed on a metallic surface of the hot plate 
(Ugo Basile Comerio, Italy) kept at 50 ± 1°C. After 30 min of 
injections of the animals, the latency in seconds was recorded 
using stop watch as the time between adjusting the animal on 
the hot plate and the appearance of symptoms of discomfort 
as licking of the hind paws, shaking, or jumping off from the 
surface. The cutoff time of 60 s was selected according to Woolfe 
and MacDonald (29).
Tail-Flick Test
A radiant heat analgesiometer (Ugo Basile Tail Flick Apparatus, 
Comerio, Italy) was used as described by D’Amour and 
Smith  (30). The light beam was focused on the mouse’s tail 
from above after wrapping the animal gently in a cotton towel. 
The recorded response was a tail flick away from a light source. 
A stopwatch was used to measure the reaction time to the near-
est second. The intensity of radiant heat was adjusted to yield 
the baseline latencies of 6–8 s. Under the current experimental 
conditions, the cutoff time was 15  s. This long cutoff time was 
imposed to reduce the intensity of the stimulus as a protection 
against tissue damage since the test was repeated every 10 min 
as reported earlier by Connor et al. (17). Each mouse was tested 
twice, before drug or vehicle administration and 10, 20, and 
30 min thereafter.
Effect of Khat Extract on Pain Perception  
in Pain Models
For each pain test, a total of five groups of male mice (n = 6–8) 
was used and received the following treatments, group I: vehicle 
(saline) served as control. The second, third, and fourth groups 
were treated with three doses of khat extract, 100, 200, and 
400  mg/kg i.p., respectively. The fifth group (positive control) 
injected with morphine (1 mg/kg, i.p.) in case of hot plate and 
tail-flick tests or diclofenac sodium (20  mg/kg, i.p.) in case of 
formalin test and acetic acid-induced writhing. In pilot experi-
ments, lower doses of khat extract 25 and 50 mg/kg are used. Only 
50 mg/kg produced slight inhibition in the acetic acid-induced 
FigUre 2 | effect of khat extract (100, 200, and 400 mg/kg ip.), morphine (1 mg/kg ip.) on the nociceptive response of mice in the hot plate. Values are 
mean ± SEM of the latency for the nociceptive behavior (seconds) (n = 6–8). Significantly different from control group at *P < 0.05 (F value = 10.991, ANOVA 
followed by Bonferroni’s post hoc test).
4
Afify et al. Mechanisms of Antinociception of Khat
Frontiers in Neurology | www.frontiersin.org March 2017 | Volume 8 | Article 69
writhing. These lower doses levels were also tested in other 
behavioral tests performed as locomotion and sedative activity 
and found to be ineffective. Therefore, we selected three dose 
levels to perform the antinociception experiments based on trials 
and on a previously published study (31), as well as considering 
the estimated amount of khat weight administered by chewers 
and the yield of khat extract. The responses were recorded for 
30  min after khat treatment according to the test performed 
as previously mentioned under Section “Experimental Groups 
and Protocols.” The use of positive control either morphine or 
diclofenac was based on the mechanism of the pain test. For 
testing the mechanisms of analgesia as in acetic acid-induced 
writhing and formalin test, diclofenac is used. Morphine is 
used as a positive control to test analgesia due to inhibition of 
centrally transmitted pain as in the tail-flick test and hot plate 
test. The time was fixed for 30  min in all pain tests for the 
comparative purposes and to minimize pain sensation in animals 
from repeated exposure to painful stimuli as heat. Similar time 
protocol was previously utilized (17).
Characterization of Antinociceptive Mechanisms of 
Khat Extract
Experiments were designed to elucidate possible mechanisms by 
which khat extract induced antinociception in mice in the four 
pain models. For each pain test, mice were divided into seven 
groups. Since the 400 mg/kg dose of khat extract produced maxi-
mal antinociceptive effect in the four pain models, we decided 
to test this dose further to study the mechanism of action of 
khat. Group I: (control) received equal volumes of saline. Group 
II: khat extract (400  mg/kg, i.p.), Group  III:  opioid receptor 
antagonist naloxone (5  mg/kg, i.p.), Group IV: the cholinergic 
antagonist atropine (2  mg/kg, i.p.), Group  V:  the selective α1 
blocker prazosin (1  mg/kg, i.p.), Group VI: the dopamine D2 
antagonist haloperidol (1.5  mg/kg, i.p.), and Group VII: the 
GABAA receptor antagonist, bicuculline (1  mg/kg, i.p.). The 
doses of the blockers used were based on pilot experiments and 
literature review (32) to block the receptors. These doses are used 
in the four pain tests and are kept constant for the comparative 
purposes. All blockers treatment were done 15  min prior to 
i.p. administration of 400 mg/kg khat extract (Groups III–VII). 
According to the test performed, the response related to the pain 
test was measured for 30 min after khat treatment as previously 
described under Section “Experimental Groups and Protocols.”
statistical analysis
Results are presented as mean ±  SEM for each experimental 
group. Statistical comparison of the data was performed by one-
way analysis of variance followed by Bonferroni’s post  hoc test 
using the GraphPad Prism software (version 5.0) for Windows. 
The level of significance was set at P < 0.05.
resUlTs
Khat extract Produced antinociception in 
all Models of Pain
Hot Plate Test
Treatment of mice with khat extract for 30  min significantly 
increased the latency only with 400 mg/kg of khat extract com-
pared to the control value of 17.75 ± 0.95 s. The positive control 
morphine (1  mg/kg i.p.) produced a significant change in the 
latency 37.33 ± 1.42 (Figure 2).
Tail-Flick Test
Compared with the control mice, i.p., administration of khat 
extract (200 and 400 mg/kg) resulted in a significant enhance-
ment of the tail-flick latency. The antinociceptive effect of the 
intermediate and high doses of khat extract was superior than 
1 mg/kg, i.p. morphine. Khat extract (400 mg/kg, i.p.) seemed to 
be most active; the peak was achieved at 10 min (10.48 ± 0.87 vs. 
6.41 ± 0.70 min), time to tail flick was doubled at 30 min post-
injection (9.41 ± 0.67 vs. 4.87 ± 0.31 min). Transforming data to 
area under curve scores indicated dose-dependent antioncicep-
tive effect of khat extract (Figure 3).
AB
FigUre 3 | Time course of khat extract (100, 200, and 400 mg/kg i.p.) and morphine (1 mg/kg, ip) in the mouse tail-flick test (a). The lower panel 
(B) shows the area under curve (AUC) from 0 to 30 min. Values are mean ± SEM (n = 6–8). Significantly different from control group at *P < 0.05 (F value = 46.997, 
ANOVA followed by Bonferroni’s post hoc test).
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Acetic Acid-Induced Abdominal Writhing
The injection of 0.6% acetic acid solution (0.1  mL/10  g) to 
mice induced a characteristic writhing response between 0 and 
30  min later, which was significantly (P <  0.05) inhibited by 
pretreatment with diclofenac (20  mg/kg). Khat extract (100, 
200, and 400 mg/kg, i.p.) injected 30 min prior to the stimulus 
injection caused dose-dependent inhibition of the abdominal 
constrictions (59.7–78.9%; P < 0.05) compared with the control 
group (Figure  4). The positive control group produced 92% 
inhibition.
Formalin test
Treatment of animals with khat extract (100, 200, and 400 mg/
kg, i.p.) or diclofenac 20 mg/kg i.p. reduced the licking time of 
hind paw by 61.8, 75, 89.2, and 3.6%, respectively, in the first 
phase (0–5  min) vs. control value of 189.5 ±  10.89  s. In the 
inflammatory phase (15–30 min), treatment with khat extract 
(100,  200,  and 400  mg/kg, i.p.) or diclofenac 20  mg/kg i.p. 
reduced the licking time by 90, 92.4, 96.6, and 74.3%, respec-
tively, from a control value of 265.12 ± 13.12 s (Figures 5A,B).
naloxone, Bicuculline, and haloperidol 
antagonized the antinociceptive effect of 
Khat extract
None of the blockers tested changed the nociceptive response 
of mice in the four animal models or produced analgesia per se 
compared to the control group (data are not shown). Khat extract 
(400 mg/kg, i.p.) significantly increased the pain latency in the 
hot plate test. The nociceptive threshold was increased by 2.2-fold 
compared to the control value, 37 ± 3.43 vs. 17.75 ± 0.95 s, respec-
tively. The antinociceptive effect of khat extract was reversed by 
prior administration of the opioid receptor antagonist naloxone 
and the GABAA antagonist bicuculine but unaffected by the cen-
trally acting dopamine D2-receptor antagonist, haloperidol, the α1 
FigUre 4 | effect of khat extract (100, 200, and 400 mg/kg i.p.) on the number of acetic acid-induced writhes in mice. Diclofenac (20 mg/kg i.p.) was 
used as positive control. Values are mean of cumulated writhings in 30 min ± SEM (n = 6–8). Significantly different from control group at *P < 0.05 (F value = 35.16, 
ANOVA followed by Bonferroni’s post hoc test).
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A
B
FigUre 5 | effect khat extract (100, 200, and 400 mg/kg i.p.), diclofenac (20 mg/kg i.p.) on the licking time in seconds of formalin-induced pain in 
mice, in the first phase (a) (0–5 min), F value = 70.030 and the second phase (B) (15–30 min). Values are mean ± SEM (n = 6–8). Significantly different from 
control group at *P < 0.05 (F value = 170.87, ANOVA followed by Bonferroni’s post hoc test).
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blocker prazosin or the cholinergic blocker atropine (Figure 6). 
In the tail-flick test, prior administration of naloxone, bicuculline, 
or haloperidol inhibited the antinociceptive effect of khat extract 
(Figure 7). On the other hand, the antinociceptive effect of khat 
extract was reversed by prior administration of naloxone or halo-
peridol during the first phase of formalin test (Figure 8A). None of 
the blockers tested significantly changed the licking time during 
the second phase of formalin test (Figure 8B) or the number of 
writhes induced by acetic acid administration (Figure 9).
DiscUssiOn
In this study, khat extract markedly increased the pain response 
in two thermally induced pain models, namely, the hot plate 
and tail-flick tests and inhibited the chemically generated 
writhing and licking responses induced by acetic acid and 
formalin injection, respectively. The opioidergic, GABAergic, 
and dopaminergic receptors but not the adrenergic or mus-
carinic ones are involved in the antinociceptive action of khat. 
The opioidergic and dopaminergic mechanisms are involved 
in the antinociceptive action of khat probably involving 
Aδ fibers. This is the first study to link the antinociceptive 
action of khat to particular pain fibers. Khat extract and its 
constituent cathinone have been shown to have analgesic 
properties in similar pain tests (17, 33, 34). In addition, cathine 
(Norpseudoephedrine), a metabolite of cathinone enhanced the 
analgesic effects of morphine in hot plate and formalin tests 
in mice (34). Thus, our results confirmed previous reports 
FigUre 7 | effect of haloperidol (1.5 mg/kg, i.p.), bicuculline (1 mg/kg, i.p.), naloxone (5 mg/kg, i.p.), atropine (2 mg/kg, i.p.), and prazosin (1 mg/kg, 
i.p.) on antinociception caused by khat extract (400 mg/kg, i.p.) on the tail-flick test in mice. Drugs or saline (control) were administered 15 min prior to 
khat extract. Values are mean ± SEM (n = 5–8). Significantly different from control group at *P < 0.05. Significantly different from khat group at #P < 0.05  
(F value = 32.140, ANOVA followed by Bonferroni’s post hoc test).
FigUre 6 | effect of haloperidol (1.5 mg/kg, i.p.), bicuculline (1 mg/kg, i.p.), naloxone (5 mg/kg, i.p.), atropine (2 mg/kg, i.p.), and prazosin (1 mg/kg, 
i.p.) on antinociception induced by khat extract (400 mg/kg, i.p.) on the hot plate latency in mice. Drugs or saline (control) were administered 15 min prior 
to khat extract. Values are mean ± SEM (n = 6–8). Significantly different from control group at *P < 0.05. Significantly different from khat group at #P < 0.05  
(F value = 28.594, ANOVA followed by Bonferroni’s post hoc test).
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A
B
FigUre 8 | effect of haloperidol (1.5 mg/kg, i.p.), bicuculline (1 mg/kg, i.p.), naloxone (5 mg/kg, i.p.), atropine (2 mg/kg, i.p.), prazosin (1 mg/kg, i.p.) 
on antinociception induced by khat extract (400 mg/kg, i.p.) on the licking time of formalin-induced pain in mice, in the first phase (a) (0–5 min)  
F value = 96.059 and the second phase (B) (15–30 min). Drugs or saline (control) were administered 15 min prior to khat extract. Values are mean ± SEM 
(n = 5–8). Significantly different from control group at *P < 0.05. Significantly different from khat group at #P < 0.05 (F value = 196.87, ANOVA followed by 
Bonferroni’s post hoc test).
that khat extract attenuated pain signals generated by different 
painful stimuli.
The present results demonstrated that the opioid antagonist, 
naloxone, attenuated the antinocieptive response of khat extract 
in hot plate, tail-flick, and first phase of formalin tests. This is 
in agreement with previous results (18, 33, 34) reported that 
cathinone-induced analgesia was antagonized by naloxone 
pretreatment. In contrast, our results indicated that naloxone 
pretreatment has no effect on the analgesic effect of khat 
in mice challenged with acetic acid and during the second 
phase of formalin test. The biphasic action of formalin has 
different nociceptive pathways. The first phase (neurogenic) is 
detected by central nociceptive afferent terminals stimulating 
the Aδ fibers. The second phase is an inflammatory response 
due to direct stimulation of chemical nociceptors resulting 
in an increased input from C fibers (28). Similarly, visceral 
pain induced by acetic acid is perceived via C fibers (27). The 
painful thermic stimuli in hot plate and tail-flick tests are also 
involving stimulation of the Aδ fibers. It has been shown that 
the opioid antagonists naloxonazine and naltriben differently 
attenuated antinociception involving C fibers compared with 
Aδ fiber-mediated response (35). Thus, it is conceivable that 
naloxone inhibited the analgesic effect of khat extract in pain 
tests mediated via Aδ fibers, namely, hot plate, tail-flick, and 
9Afify et al. Mechanisms of Antinociception of Khat
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first phase of formalin test but not those activating the C fibers 
as second phase of formalin test and acetic acid-induced writh-
ing. The differential antinociceptive effect for analgesic agents 
according to the painful stimulus was reported earlier for khat 
(17), morphine (22, 36), and for other centrally acting drugs 
such as amphetamine (18) and nicotine (37). Taken together, 
the opioidergic mechanism is involved in the antinociceptive 
action of khat probably associated with Aδ fibers.
Pretreatment of mice with bicuculline attenuated the anti-
nociceptive effect of khat extract in hot plate and tail-flick tests. 
Reports about the involvement of GABA in khat analgesia are 
rare. One study reported that prolonged khat administration 
resulted in excessive release followed by decreased GABA 
concentration in different brain areas (38). Since bicuculline 
is a competitive antagonist of GABAA receptor, the behavioral 
effects of khat extract following bicuculline administration can 
only be due to reversal of GABA-mediated analgesia. Thus, it 
could be speculated that the acute khat consumption adopted in 
our study increased GABA level in brain as previously detected 
in the early phase of chronic khat habituation (39). Therefore, the 
GABAA antagonist, bicuculline, attenuated the antinociceptive 
action of khat extract in hot plate and tail-flick tests.
Interestingly, haloperidol, the D2-receptor antagonist, 
reversed the antinociceptive effect of khat extract in the tail-flick 
test and the first phase of formalin test, but not the hot plate 
test, second phase of the formalin test, and acetic acid test. As 
reported earlier, haloperidol did not inhibit cathinone analgesia 
in acetic acid-induced writhing (33). Cathinone increased the 
release of dopamine from presynaptic sites and increased 
extracellular dopamine concentration (40, 41). Both hot plate 
and tail-flick tests are thermic stimuli involving stimulation of 
Aδ fibers; yet, they follow different neural pathways. The tail 
FigUre 9 | effect of haloperidol (1.5 mg/kg, i.p.), bicuculline (1 mg/kg, i.p.), naloxone (5 mg/kg, i.p.), atropine (2 mg/kg, i.p.), and prazosin (1 mg/kg, 
i.p.) on antinociception induced by khat extract (400 mg/kg, i.p.) in acetic acid-induced writhing in mice. Drugs or saline (control) were administered 
15 min prior to khat extract. Values are mean ± SEM (n = 5–8). Significantly different from control group at *P < 0.05. Significantly different from khat group at 
#P < 0.05 (F value = 44.136, ANOVA followed by Bonferroni’s post hoc test).
flick is a spinal reflex, whereas the hot plate response is under 
supraspinal control (36, 37, 42, 43). It is a reasonable question 
to query whether the antagonistic effect of haloperidol on khat 
analgesia in the tail-flick test is mediated spinally through the 
dopaminergic pathway and not supraspinally as in the hot plate 
test. Since our results indicated that khat abolished all types 
of painful sensations, the analgesic effect produced by sys-
temically administered khat occurs because of the potentiated 
interaction that exists between spinal and supraspinal effects 
achieved simultaneously suggesting a cross-talk between the 
two pathways. Thus, the results in our hand only excludes a 
specific role of dopamine in mediating the effect of khat extract 
on pain signals induced in hot plate test or those initiated 
via stimulation of C fibers following acetic acid and formalin 
administration.
One may argue that the results of antinociceptive action 
of khat could be attributed to the sedative action or the effect 
of the khat extract on the locomotor activity. In fact, cathi-
none administration in rats (44, 45) and mice (46) markedly 
increased spontaneous locomotor activity almost comparable 
with amphetamine (47). Similar increases in locomotor activity 
were observed after acute and subchronic oral administration 
of C. edulis leaves or cathinone in rats (48, 49). Moreover, both 
antinociception and locomotion are mediated via different path-
ways. Reports indicated that the potent antinociceptive action 
of morphine is associated with increased locomotor activity 
in mice (50). This confirms that the observed antinociceptive 
action of khat extract in the pain tests is not attributed to the 
effect on motor activity.
Our results indicated that the muscarinic antagonist atro-
pine and the selective α1 blocker prazosin did not modify the 
analgesic effect of khat extract. This is the first study to address 
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whether cholinergic or α1 receptors are involved in khat anal-
gesia. Agonists of cholinergic and adrenergic systems are targets 
for the treatment of pain (51). Previous studies have shown 
that the non-selective α blocker phenoxybenzamine reversed 
cathinone-induced analgesia (33). The vasoconstrictor effect 
of khat on coronary vessels was independent of α1 adrenergic 
receptor stimulation (52). In a randomized clinical study, it was 
found that the α1 receptors are not involved in mediating the 
cardiovascular effects of khat in humans (53). Therefore, the 
present results allow the suggestion that the analgesic effect of 
khat is not mediated by direct stimulation of α1 receptors and 
most probably through mechanisms involving noradrenaline 
release and stimulation of α2 receptors. This warrants further 
studies using selective α2 antagonists.
Newly synthesized muscarinic agonists are proved to be 
analgesic both in vitro and in vivo (54). Similarly, the inability 
of atropine to antagonize the antinociceptive action of khat 
extract on tested pain signals excluded a direct interaction 
of khat extract with muscarinic receptors. It is reported that 
the anticholinesterase compound physostigmine attenuated 
the painful stimuli in formalin test (55). Khat extract was 
found to inhibit acetylcholinesterase enzyme in khat-chewing 
individuals (56). Recently, amphetamine and its derivatives 
are reported to inhibit acetylcholinesterase activity in rats 
(57, 58). If khat analgesia followed the same scenario, it is 
conceivable that khat by inhibiting cholinesterase enzyme 
produced accumulation of acetylcholine, which exerts an 
antinociceptive action. This explains why the cholinergic 
antagonist atropine that act on the receptor level did not 
antagonize the antinociceptive action of khat. Neuronal 
nicotinic receptors also showed analgesic effects in experi-
mental and clinical trials (59). Whether the antinociceptive 
effect of khat is mediated through the activation of nicotinic 
receptors caused by accumulated acetylcholine needs further 
investigations.
cOnclUsiOn
Khat extract proved to be analgesic against thermic and chemical 
noxious stimuli in different pain models. The opioidergic and 
dopaminergic pathways are involved in the antinociceptive action 
of khat probably by stimulating Aδ fibers. The analgesic effect of 
khat is also mediated via GABAA receptors. The antinociceptive 
action of khat is not involving direct interaction with α1 receptors 
or the muscarinic cholinergic receptors. Further pharmacologi-
cal techniques such as binding studies and electrophysiological 
procedures may be useful to fully elucidate the antinociceptive 
effects of khat extract.
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